296 related articles for article (PubMed ID: 30071038)
1. Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study.
Figueroa R; Alfonso A; López-Picazo J; Gil-Bazo I; García-Mouriz A; Hermida J; Páramo JA; Lecumberri R
PLoS One; 2018; 13(8):e0200220. PubMed ID: 30071038
[TBL] [Abstract][Full Text] [Related]
2. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
[TBL] [Abstract][Full Text] [Related]
3. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.
Brown A
Am J Health Syst Pharm; 2012 Mar; 69(6):469-81. PubMed ID: 22382477
[TBL] [Abstract][Full Text] [Related]
4. Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy.
van Es N; Bleker SM; Wilts IT; Porreca E; Di Nisio M
Drugs; 2016 Mar; 76(3):331-41. PubMed ID: 26729187
[TBL] [Abstract][Full Text] [Related]
5. Stratification of venous thromboembolism risk in burn patients by Caprini score.
Li Q; Ba T; Wang LF; Chen Q; Li F; Xue Y
Burns; 2019 Feb; 45(1):140-145. PubMed ID: 30253959
[TBL] [Abstract][Full Text] [Related]
6. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
7. Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice. An Observational Study in Routine Clinical Practice.
den Exter PL; Hooijer J; van der Hulle T; van Oosten JP; Dekkers OM; Klok FA; Huisman MV
Thromb Haemost; 2017 Nov; 117(11):2163-2167. PubMed ID: 28981552
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.
Rothberg MB; Pekow PS; Lahti M; Lindenauer PK
J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer.
Fuentes HE; Oramas DM; Paz LH; Casanegra AI; Mansfield AS; Tafur AJ
Thromb Res; 2017 Jun; 154():28-34. PubMed ID: 28402864
[TBL] [Abstract][Full Text] [Related]
10. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
[TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparin (LMWH) for primary thrombo-prophylaxis in patients with solid malignancies - systematic review and meta-analysis.
Ben-Aharon I; Stemmer SM; Leibovici L; Shpilberg O; Sulkes A; Gafter-Gvili A
Acta Oncol; 2014 Sep; 53(9):1230-7. PubMed ID: 25162954
[TBL] [Abstract][Full Text] [Related]
12. TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial.
Klaassen ILM; Lauw MN; van de Wetering MD; Biemond BJ; Middeldorp S; Abbink FCH; Bierings M; Te Loo DMMW; Pieters R; van der Sluis IM; Tissing WJE; Michel Zwaan C; Heleen van Ommen C
BMC Pediatr; 2017 May; 17(1):122. PubMed ID: 28486976
[TBL] [Abstract][Full Text] [Related]
13. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Rasmussen MS; Jørgensen LN; Wille-Jørgensen P
Cochrane Database Syst Rev; 2009 Jan; (1):CD004318. PubMed ID: 19160234
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of pharmacological thromboprophylaxis for hospitalized patients with cirrhosis: a single-center retrospective cohort study.
Shatzel J; Dulai PS; Harbin D; Cheung H; Reid TN; Kim J; James SL; Khine H; Batman S; Whyman J; Dickson RC; Ornstein DL
J Thromb Haemost; 2015 Jul; 13(7):1245-53. PubMed ID: 25955079
[TBL] [Abstract][Full Text] [Related]
15. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review.
Ribic C; Lim W; Cook D; Crowther M
J Crit Care; 2009 Jun; 24(2):197-205. PubMed ID: 19327323
[TBL] [Abstract][Full Text] [Related]
17. Bemiparin in oncology.
Monreal Bosch M; Vignoli A; Lecumberri Villamediana R; Prandoni P
Drugs; 2010 Dec; 70 Suppl 2():35-42. PubMed ID: 21162608
[TBL] [Abstract][Full Text] [Related]
18. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.
Dargaud Y; Rugeri L; Vergnes MC; Arnuti B; Miranda P; Negrier C; Bestion A; Desmurs-Clavel H; Ninet J; Gaucherand P; Rudigoz RC; Berland M; Champion F; Trzeciak MC
Br J Haematol; 2009 Jun; 145(6):825-35. PubMed ID: 19388925
[TBL] [Abstract][Full Text] [Related]
19. Prevention of venous thromboembolism in the cancer surgery patient.
Spyropoulos AC; Brotman DJ; Amin AN; Deitelzweig SB; Jaffer AK; McKean SC
Cleve Clin J Med; 2008 Apr; 75 Suppl 3():S17-26. PubMed ID: 18496913
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia.
Khanal N; Bociek RG; Chen B; Vose JM; Armitage JO; Bierman PJ; Maness LJ; Lunning MA; Gundabolu K; Bhatt VR
Am J Hematol; 2016 Nov; 91(11):E468-E472. PubMed ID: 27489982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]